213 studies found for:    Pituitary Tumors
Show Display Options
Rank Status Study
1 Recruiting Ga-68-DOTATOC -PET in the Management of Pituitary Tumours
Condition: Pituitary Tumours
Intervention: Procedure: Gallium-68 DOTATOC PET
2 Withdrawn Temozolomide in Treating Patients With Invasive Pituitary Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide;   Genetic: DNA methylation analysis;   Genetic: microarray analysis;   Genetic: protein expression analysis;   Genetic: proteomic profiling;   Other: laboratory biomarker analysis
3 Not yet recruiting Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors
Conditions: Pituitary Tumor;   ACTH-producing Pituitary Tumour
Intervention: Drug: Pasireotide LAR
4 Unknown  Pituitary Tumor Surveillance: Pathogenic Correlation
Condition: Pituitary Tumor
Intervention:
5 Unknown  The Observational Study of Growth Hormone-secreting Pituitary Tumors
Conditions: Acromegaly;   Pituitary Tumor
Intervention:
6 Completed Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors
Condition: Pituitary Tumors
Intervention: Drug: Technetium Tc 99m EC20
7 Completed Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
Conditions: Acromegaly;   Nonfunctioning Pituitary Tumor
Intervention:
8 Recruiting Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
Conditions: Pituitary Adenomas;   Prolactinomas
Intervention: Drug: Lapatinib
9 Recruiting An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Conditions: Abnormalities;   Craniopharyngioma;   Cushing's Syndrome;   Endocrine Disease;   Pituitary Neoplasm
Intervention:
10 Completed Follow-up Evaluation of Photo-Dynamic Therapy for Pituitary Tumours
Condition: Pituitary Neoplasms
Intervention:
11 Recruiting Effects of Total Intravenous Anesthesia With Propofol-remifentanil Versus Inhalational Anesthesia With Sevoflurane on Quality of Recovery in Patients Undergoing Transsphenoidal Surgery for Pituitary Tumor
Condition: Pituitary Tumor
Interventions: Drug: total intravenous anesthesia (TIVA);   Drug: inhalation anesthesia group
12 Active, not recruiting Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors
Conditions: Pituitary Tumor;   Pain
Interventions: Drug: IV Caldolor (IV Ibuprofen);   Drug: IV Ibuprofen placebo
13 Terminated
Has Results
Rosiglitazone in Treating Patients With Pituitary Tumors
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: rosiglitazone maleate
14 Active, not recruiting Identification of GENEtic Markers of Aggressiveness and Malignancy by Array Comparative Genomic Hybrization Analysis (CGH)
Condition: Pituitary Tumors
Intervention:
15 Recruiting Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
Conditions: Pituitary Adenoma;   Pituitary Tumor
Interventions: Procedure: Surgical intervention for CNFA;   Radiation: Radiotherapy for CNFA
16 Terminated
Has Results
Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)
Condition: Cushing's Disease
Intervention: Drug: rosiglitazone maleate
17 Active, not recruiting Peri-Operative Steriod Management in Patients
Conditions: Pituitary Adenoma;   Pituitary Diseases
Interventions: Drug: hydrocortisone;   Drug: dexamethasone
18 Not yet recruiting Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal Surgery
Condition: Pituitary Neoplasms
Interventions: Drug: Dexmedetomidine;   Drug: Sodium Chloride 0.9%
19 Terminated Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas
Conditions: Growth Hormone Deficiency;   Pituitary Tumor
Intervention:
20 Withdrawn Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
Conditions: Merkel Cell Carcinoma;   Islet Cell Carcinoma;   Neuroendocrine Carcinoma;   Pituitary Tumor
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1;   Procedure: alternative product therapy;   Procedure: biological therapy;   Procedure: biologically based therapies;   Procedure: cancer prevention intervention;   Procedure: complementary and alternative therapy;   Procedure: differentiation therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years